The Diagnostic Imaging mammography modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of mammography, including 2D digital mammography, digital breast tomosynthesis, and breast ultrasound.
June 16th 2025
New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®
November 12-14, 2025
Register Now!
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
Annual Hawaii Cancer Conference
January 24-25, 2026
Register Now!
43rd Annual Miami Breast Cancer Conference®
March 5-8, 2026
Register Now!
19th Annual New York GU Cancers Congress™
March 13-14, 2026
Register Now!
Mastering Advances in Managing Unresectable and Metastatic NSCLC—Immunotherapy, Targeted Therapies, and Emerging Strategies
View More
(CME Credit) Advancing Outcomes in Limited-Stage Small Cell Lung Cancer: From Evidence to Practice
View More
Blood test monitors breast cancer treatment effectiveness
September 16th 2009With the goal of tailoring cancer interventions for the individual, researchers at the Lombardi Comprehensive Cancer Center at Georgetown University have published the results of a prospective study that validates the use of a simple blood test to help doctors more reliably assess treatment effectiveness for patients with metastatic breast cancer.
Digital mammo proves better than film-screen for diagnosing DCIS
September 1st 2009The largest population-based study to date comparing film-screen mammography and full-field digital mammography has found the digital approach is superior for visualizing microcalcifications deemed crucial to diagnosing ductal carcinoma in situ. No other significant difference in the diagnostic capabilities of the digital and analog approaches was identified.
Short pauses in hormone therapy don’t improve mammography
July 8th 2009Older women who take a short break from hormone therapy do not experience fewer false positives on their screening mammograms than women who continue to take the drugs, though a suspension is associated with small changes in breast density.
Surgical gel mimics breast microcalcifications
May 13th 2009FloSeal Matrix Hemostatic Sealant may stanch bleeding when other techniques fail, but it also spawns microcalcifications on digital or analog screening mammography that could lead to false positives for breast cancer, according to a case series collected by Loyola University radiologists.
Mistrust, costs reduce breast cancer screening among minorities
April 27th 2009Distrust of healthcare providers, cultural barriers, lack of information about the benefits of screening, or simply the need to cut corners might all contribute to the levels of compliance for breast cancer screening among minorities, including African American, Hispanic, and lesbian/bisexual women, recent studies show.
Disagreement continues to dog screening mammography
April 1st 2009In a commentary on the mammography controversypublished in Diagnostic Imaging six and ahalf years ago,2 I discussed how two prestigiousgroups of scientists analyzed data from the eightmost commonly recognized clinical trials onscreening mammography conducted to date andarrived at opposite conclusions.
Industry News: Supersonic Imagine reinvigorates ultrasound R&D
March 10th 2009It wasn’t too long ago that ultrasound was a roiling sea of innovation and new product releases, spurred by a rivalry among Diasonics, ATL, Hewlett-Packard (Agilent Technologies), and Acuson. Since these companies’ acquisition by GE, Philips, and Siemens, the waters have calmed. Supersonic Imagine plans to begin making some waves -- and soon.
Studies suggest new value for digital breast tomosynthesis
March 6th 2009Digital breast tomosynthesis was found to be superior to 2D digital mammography for determining tumor boundaries, a value at a time when more women with breast cancer are choosing breast conservation therapy, according to a study presented Friday.
Report from ECR: Studies suggest new value for digital breast tomosynthesis
March 6th 2009Digital breast tomosynthesis was found to be superior to 2D digital mammography for determining tumor boundaries, a value at a time when more women with breast cancer are choosing breast conservation therapy, according to a study presented Friday.
Declining mammography rates portend potential preventive care crisis
February 23rd 2009Breast cancer screening rates among young premenopausal women are declining, according to a study on mammography use from the Centers for Disease Control and Prevention. Mammographers worry that the trend could lead to the erosion of screening services and of preventive care in general.